{
    "eid": "2-s2.0-85151943168",
    "title": "Chikungunya vaccines: An update in 2023",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "chikungunya virus",
        "clinical trials",
        "mRNA vaccines",
        "preclinical chikungunya vaccines",
        "viral vector vaccines"
    ],
    "authors": [
        "Pitchapa Roongaraya",
        "Siwaporn Boonyasuppayakorn"
    ],
    "citedby-count": 0,
    "ref-count": 88,
    "ref-list": [
        "Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa",
        "Chikungunya disease outbreak, Reunion Island",
        "Infection with chikungunya virus in Italy: an outbreak in a temperate region",
        "Epidemiology of Chikungunya in the Americas",
        "Spread of a Novel Indian Ocean Lineage Carrying E1-K211E/E2-V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa",
        "Global transmission and evolutionary dynamics of the Chikungunya virus",
        "Niche conservatism of Aedes albopictus and Aedes aegypti-two mosquito species with different invasion histories",
        "Diagnosis and molecular characterization of Chikungunya Virus Infections",
        "Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy",
        "Chikungunya virus infection during pregnancy, Reunion, France, 2006",
        "Mxra8 is a receptor for multiple arthritogenic alphaviruses",
        "Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography",
        "Chikungunya virus nonstructural protein 2-mediated host shut-off disables the unfolded protein response",
        "Network mapping among the functional domains of Chikungunya virus nonstructural proteins",
        "Structure-function relationship of Chikungunya nsP2 protease: A comparative study with papain",
        "NTPase and 5\u2019-RNA triphosphatase activities of Chikungunya virus nsP2 protein",
        "Multiple Host Factors Interact with the Hypervariable Domain of Chikungunya Virus nsP3 and Determine Viral Replication in Cell-Specific Mode",
        "Multiple roles of the nonstructural protein 3 (nsP3) alphavirus unique domain (AUD) during Chikungunya virus genome replication and transcription",
        "Understanding the interactability of chikungunya virus proteins via molecular recognition feature analysis",
        "Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate",
        "Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression",
        "Chikungunya virus capsid protein contains nuclear import and export signals",
        "Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection",
        "The role of E3 in pH protection during alphavirus assembly and exit",
        "Internally located cleavable signal sequences direct the formation of Semliki Forest virus membrane proteins from a polyprotein precursor",
        "Type I IFN controls chikungunya virus via its action on nonhematopoietic cells",
        "Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response",
        "Focus on Chikungunya pathophysiology in human and animal models",
        "Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1:A226V mutation",
        "Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation",
        "Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock",
        "A mouse model for chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease",
        "Immuno-biology of Chikungunya and implications for disease intervention",
        "The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response",
        "Chikungunya virus: clinical aspects and treatment-A Review",
        "Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/ arthritis",
        "Rheumatic manifestations of chikungunya: emerging concepts and interventions",
        "Chikungunya Arthritis Mechanisms in the Americas: A Cross-Sectional Analysis of Chikungunya Arthritis Patients Twenty-Two Months After Infection Demonstrating No Detectable Viral Persistence in Synovial Fluid",
        "A Rodent Model of Chikungunya Virus Infection in RAG1-/-Mice, with Features of Persistence, for Vaccine Safety Evaluation",
        "An Essential Role of Antibodies in the Control of Chikungunya Virus Infection",
        "Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling",
        "Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response",
        "A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice",
        "Human muscle satellite cells as targets of Chikungunya virus infection",
        "Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against chikungunya in the A129 mouse model",
        "Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate",
        "Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in antiviral immunity",
        "Animal Models of Chikungunya Virus Infection and Disease",
        "Beyond Fever and Pain: Diagnostic Methods for Chikungunya Virus",
        "Molecular surveillance of arboviruses circulation and co-infection during a large chikungunya virus outbreak in Thailand, October 2018 to February 2020",
        "A performance comparison between fluorescent immunoassay and immunochromatography for rapid dengue detection in clinical specimens",
        "Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common",
        "Design and estimation for evaluating principal surrogate markers in vaccine trials",
        "Defining a correlate of protection for chikungunya virus vaccines",
        "Production and evaluation of a formalin-killed Chikungunya vaccine",
        "Immunogenicity of purified, inactivated chikungunya virus in monkeys",
        "Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus",
        "US Military contributions to the global response to pandemic chikungunya",
        "Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein",
        "Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218",
        "Immunologic interference from sequential administration of live attenuated alphavirus vaccines",
        "Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial",
        "Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera",
        "Chikungunya vaccine candidate is highly attenuated and protects non-human primates against telemetrically monitored disease following a single dose",
        "Novel Chikungunya Vaccine Candidate with an IRES-Based Attenuation and Host Range Alteration Mechanism",
        "A virus-like particle vaccine for epidemic Chikungunya virus protects non-human primates against infection",
        "Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial",
        "Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial",
        "Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial",
        "Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects",
        "Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines",
        "A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus",
        "Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial",
        "Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine",
        "Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial",
        "Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus",
        "A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease",
        "A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa",
        "The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial",
        "A chimeric vesiculo/alphavirus is an effective alphavirus vaccine",
        "A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice",
        "Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge",
        "A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection",
        "A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}